Can Vascular Endothelial Growth Factor and Microvessel Density Be Used as Prognostic Biomarkers for Colorectal Cancer? A Systematic Review and Meta-Analysis

Background. Vascular endothelial growth factor (VEGF) and microvessel density (MVD) are associated with greater incidence of metastases and decreased survival. Whether they can be used as prognostic indicators of colorectal cancer (CRC) is still controversial. Methods. The authors performed a meta-a...

Full description

Saved in:
Bibliographic Details
Main Authors: Yibaina Wang, Xiaoping Yao, Jie Ge, Fulan Hu, Yashuang Zhao
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2014/102736
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559679559958528
author Yibaina Wang
Xiaoping Yao
Jie Ge
Fulan Hu
Yashuang Zhao
author_facet Yibaina Wang
Xiaoping Yao
Jie Ge
Fulan Hu
Yashuang Zhao
author_sort Yibaina Wang
collection DOAJ
description Background. Vascular endothelial growth factor (VEGF) and microvessel density (MVD) are associated with greater incidence of metastases and decreased survival. Whether they can be used as prognostic indicators of colorectal cancer (CRC) is still controversial. Methods. The authors performed a meta-analysis using the results of a literature search of databases of PubMed and EMBASE, and the references of articles included in the analysis. Meta-analysis was performed using random effects model and hazard ratios (HRs) and 95% confidence intervals (CIs) as effect measures. Results. Twenty studies contributed to the analysis of VEGF, of which 16 were used for overall survival (OS) and 9 for disease-free survival (DFS). High VEGF levels has a relationship with unfavorable survival (OS: HR = 1.98, 95% CI: 1.30–3.02; DFS: HR = 2.10, 95% CI: 1.26–3.49) and a 4.22-fold increase in the rate of distant metastases. Analysis was performed on 18 studies for MVD; the results showed that patients with high MVD expression in tumors appeared to have poorer overall survival (HR = 1.39, 95% CI: 1.22–1.58) and were at a greater risk of having unfavorable clinical characteristics related to prognosis. Corresponding results were obtained from quantitative and/or qualitative analysis of clinicopathological. Conclusions. The meta-analysis demonstrates that VEGF and MVD can be used as prognostic biomarkers for CRC patients.
format Article
id doaj-art-2a5b7330f33846dcb942f917800026da
institution Kabale University
issn 2356-6140
1537-744X
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-2a5b7330f33846dcb942f917800026da2025-02-03T01:29:23ZengWileyThe Scientific World Journal2356-61401537-744X2014-01-01201410.1155/2014/102736102736Can Vascular Endothelial Growth Factor and Microvessel Density Be Used as Prognostic Biomarkers for Colorectal Cancer? A Systematic Review and Meta-AnalysisYibaina Wang0Xiaoping Yao1Jie Ge2Fulan Hu3Yashuang Zhao4Department of Epidemiology, Public Health College, Harbin Medical University, 157 Baojian Street, Nangang District, Harbin, Heilongjiang 150081, ChinaDepartment of Epidemiology, Public Health College, Harbin Medical University, 157 Baojian Street, Nangang District, Harbin, Heilongjiang 150081, ChinaDepartment of Epidemiology, Public Health College, Harbin Medical University, 157 Baojian Street, Nangang District, Harbin, Heilongjiang 150081, ChinaDepartment of Epidemiology, Public Health College, Harbin Medical University, 157 Baojian Street, Nangang District, Harbin, Heilongjiang 150081, ChinaDepartment of Epidemiology, Public Health College, Harbin Medical University, 157 Baojian Street, Nangang District, Harbin, Heilongjiang 150081, ChinaBackground. Vascular endothelial growth factor (VEGF) and microvessel density (MVD) are associated with greater incidence of metastases and decreased survival. Whether they can be used as prognostic indicators of colorectal cancer (CRC) is still controversial. Methods. The authors performed a meta-analysis using the results of a literature search of databases of PubMed and EMBASE, and the references of articles included in the analysis. Meta-analysis was performed using random effects model and hazard ratios (HRs) and 95% confidence intervals (CIs) as effect measures. Results. Twenty studies contributed to the analysis of VEGF, of which 16 were used for overall survival (OS) and 9 for disease-free survival (DFS). High VEGF levels has a relationship with unfavorable survival (OS: HR = 1.98, 95% CI: 1.30–3.02; DFS: HR = 2.10, 95% CI: 1.26–3.49) and a 4.22-fold increase in the rate of distant metastases. Analysis was performed on 18 studies for MVD; the results showed that patients with high MVD expression in tumors appeared to have poorer overall survival (HR = 1.39, 95% CI: 1.22–1.58) and were at a greater risk of having unfavorable clinical characteristics related to prognosis. Corresponding results were obtained from quantitative and/or qualitative analysis of clinicopathological. Conclusions. The meta-analysis demonstrates that VEGF and MVD can be used as prognostic biomarkers for CRC patients.http://dx.doi.org/10.1155/2014/102736
spellingShingle Yibaina Wang
Xiaoping Yao
Jie Ge
Fulan Hu
Yashuang Zhao
Can Vascular Endothelial Growth Factor and Microvessel Density Be Used as Prognostic Biomarkers for Colorectal Cancer? A Systematic Review and Meta-Analysis
The Scientific World Journal
title Can Vascular Endothelial Growth Factor and Microvessel Density Be Used as Prognostic Biomarkers for Colorectal Cancer? A Systematic Review and Meta-Analysis
title_full Can Vascular Endothelial Growth Factor and Microvessel Density Be Used as Prognostic Biomarkers for Colorectal Cancer? A Systematic Review and Meta-Analysis
title_fullStr Can Vascular Endothelial Growth Factor and Microvessel Density Be Used as Prognostic Biomarkers for Colorectal Cancer? A Systematic Review and Meta-Analysis
title_full_unstemmed Can Vascular Endothelial Growth Factor and Microvessel Density Be Used as Prognostic Biomarkers for Colorectal Cancer? A Systematic Review and Meta-Analysis
title_short Can Vascular Endothelial Growth Factor and Microvessel Density Be Used as Prognostic Biomarkers for Colorectal Cancer? A Systematic Review and Meta-Analysis
title_sort can vascular endothelial growth factor and microvessel density be used as prognostic biomarkers for colorectal cancer a systematic review and meta analysis
url http://dx.doi.org/10.1155/2014/102736
work_keys_str_mv AT yibainawang canvascularendothelialgrowthfactorandmicrovesseldensitybeusedasprognosticbiomarkersforcolorectalcancerasystematicreviewandmetaanalysis
AT xiaopingyao canvascularendothelialgrowthfactorandmicrovesseldensitybeusedasprognosticbiomarkersforcolorectalcancerasystematicreviewandmetaanalysis
AT jiege canvascularendothelialgrowthfactorandmicrovesseldensitybeusedasprognosticbiomarkersforcolorectalcancerasystematicreviewandmetaanalysis
AT fulanhu canvascularendothelialgrowthfactorandmicrovesseldensitybeusedasprognosticbiomarkersforcolorectalcancerasystematicreviewandmetaanalysis
AT yashuangzhao canvascularendothelialgrowthfactorandmicrovesseldensitybeusedasprognosticbiomarkersforcolorectalcancerasystematicreviewandmetaanalysis